Computer-Assisted Vacuum Thrombectomy Shows Faster Recovery vs Anticoagulation in Acute Intermediate-High Risk Pulmonary Embolism: Study Dr. Shravani Dali27 Nov 2025 8:45 AM ISTPatients with intermediate-high risk pulmonary embolism have an elevated right-to-left ventricular diameter ratio and are at risk of early clinical...
Coronary artery stenosis may protect patients from the effects of pulmonary embolism: Study Dr. Kamal Kant Kohli13 Nov 2025 9:00 PM ISTAcute pulmonary embolism (PE) is a life-threatening condition in which blood clots block vessels carrying deoxygenated blood from the heart to the...
Study links heart attacks and late-onset epilepsy in older adults Dr. Kamal Kant Kohli10 Nov 2025 8:45 PM ISTOlder adults who have a heart attack may be more likely to develop epilepsy later in life, according to a study published November 5, 2025 in...
STORM-PE Trial: Mechanical Thrombectomy Shows Superior Heart Function Recovery in Pulmonary Embolism Medha Baranwal3 Nov 2025 8:45 AM ISTUSA: Results from the pivotal STORM-PE randomized controlled trial, presented as a Late-Breaking Clinical Trial at TCT 2025, have provided the first...
PEACE Score Accurately Predicts Echo Abnormalities in Pulmonary Embolism Patients: Study Shows Medha Baranwal23 July 2025 8:45 PM ISTA recent study published in BMC Emergency Medicine has validated the Pulmonary Embolism Advanced Cardiac Evaluation (PEACE) Score as a reliable tool...
Biocon Pharma gets USFDA nod for deep vein thrombosis drug Rivaroxaban Ruchika Sharma16 May 2025 2:57 PM ISTBangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval for its Abbreviated New Drug...
Lupin Rivaroxaban Tablets approved by USFDA Ruchika Sharma16 May 2025 12:23 PM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...
Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban Ruchika Sharma14 April 2025 11:30 AM ISTAurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Elevated Biomarkers Predict Long-Term Mortality Risks in Patients with Suspected Pulmonary Embolism: Study Medha Baranwal26 Sept 2024 8:15 PM ISTFinland: Recent research, published in the European Heart Journal Open has highlighted the critical role of several biomarkers-D-dimer, cardiac...
Frequent and Severe COPD Exacerbations Linked to Higher Risks of Myocardial Infarction and Pulmonary Embolism: Study Medha Baranwal29 Aug 2024 8:00 PM ISTSweden: A recent study into chronic obstructive pulmonary disease (COPD) has unveiled a troubling correlation between the frequency and severity of...
Frequent COPD Exacerbations Linked to Increased Risk of Heart Attack and Pulmonary Embolism: Study Dr Riya Dave22 Aug 2024 5:00 AM ISTResearchers have found out that in patients with frequent acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) raise the risk of...
